BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+12.02%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$142M
AUM Growth
+$142M
Cap. Flow
-$4.29M
Cap. Flow %
-3.02%
Top 10 Hldgs %
70.5%
Holding
66
New
2
Increased
5
Reduced
5
Closed
2

Top Buys

1
PRTA icon
Prothena Corp
PRTA
$994K
2
BDSX icon
Biodesix
BDSX
$709K
3
VTYX icon
Ventyx Biosciences
VTYX
$419K
4
SRPT icon
Sarepta Therapeutics
SRPT
$276K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$180K

Top Sells

1
SLNO icon
Soleno Therapeutics
SLNO
$5.73M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$602K
3
CGEM icon
Cullinan Oncology
CGEM
$256K
4
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
$225K
5
FHTX icon
Foghorn Therapeutics
FHTX
$172K

Sector Composition

1 Healthcare 93.28%
2 Energy 4.01%
3 Consumer Staples 0.08%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$96B
$51.7M 36.43% 727,785 – –
ELUT icon
2
Elutia
ELUT
$96.7M
$10.2M 7.19% 1,418,123 – –
NBIX icon
3
Neurocrine Biosciences
NBIX
$13.8B
$9.05M 6.37% 85,240 – –
PRTA icon
4
Prothena Corp
PRTA
$441M
$7.21M 5.08% 118,945 +16,397 +16% +$994K
QDEL icon
5
QuidelOrtho
QDEL
$1.95B
$4.38M 3.09% 61,306 – –
ACAD icon
6
Acadia Pharmaceuticals
ACAD
$4.38B
$4.08M 2.87% 249,400 – –
OVV icon
7
Ovintiv
OVV
$10.8B
$3.87M 2.73% 84,200 – –
AXDX
8
DELISTED
Accelerate Diagnostics
AXDX
$3.42M 2.41% 2,252,388 – –
UTHR icon
9
United Therapeutics
UTHR
$13.8B
$3.14M 2.21% 15,000 – –
BDSX icon
10
Biodesix
BDSX
$62.6M
$3.01M 2.12% 2,370,071 +558,659 +31% +$709K
CLR
11
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$2.58M 1.82% 38,600 – –
FHTX icon
12
Foghorn Therapeutics
FHTX
$286M
$2.27M 1.6% 264,843 -20,000 -7% -$172K
ALBO
13
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$2.27M 1.59% 117,000 +4,000 +4% +$77.4K
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.23M 1.57% 14,730 -270 -2% -$40.8K
HROW icon
15
Harrow
HROW
$1.44B
$2.17M 1.53% 180,000 – –
MASI icon
16
Masimo
MASI
$7.59B
$2.16M 1.52% 15,280 – –
PHR icon
17
Phreesia
PHR
$1.88B
$2.11M 1.48% 82,700 – –
GOSS icon
18
Gossamer Bio
GOSS
$562M
$1.91M 1.34% 159,088 – –
VTYX icon
19
Ventyx Biosciences
VTYX
$171M
$1.57M 1.11% 45,000 +12,000 +36% +$419K
KPTI icon
20
Karyopharm Therapeutics
KPTI
$61.7M
$1.47M 1.04% 269,332 – –
CORT icon
21
Corcept Therapeutics
CORT
$7.35B
$1.28M 0.9% 50,000 – –
INBX
22
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.27M 0.89% 70,448 – –
CYTK icon
23
Cytokinetics
CYTK
$4.23B
$1.21M 0.85% 25,000 – –
AVEO
24
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.15M 0.81% 140,000 – –
ALKS icon
25
Alkermes
ALKS
$4.78B
$1.12M 0.79% 50,000 – –
1
2 3